MedTrace Logo

Proof of Concept (POC) Study of the Soliton's Acoustic Scar Reduction (ASR) Treatment for the Treatment of Keloid Scar

NCT04016610 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2021-09-28

No results posted yet for this study

Summary

To evaluate the safety, and efficacy of the ASR device for the temporary improvement in the appearance of a keloids.

Conditions

  • Keloid Scar

Interventions

DEVICE

Soliton's Acoustic Scar Reduction (SAR)

Treatment of keloid scars for the temporary improvement in appearance.

Sponsors & Collaborators

  • Emergent Clinical Consulting, LLC

    collaborator INDUSTRY

  • Soliton

    lead INDUSTRY

Principal Investigators

  • Christopher Capelli, MD · Soliton, Inc.

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-07-09
Primary Completion
2020-02-12
Completion
2020-02-12
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04016610 on ClinicalTrials.gov